The role of active treatment in early prostate cancer

Radiotherapy and Oncology

Volumn 57, Issue 3, 2000, Pages 251-258

  Denis, Louis J ^a  

^a Oncology Centre of Antwerp   (Belgium)

Author keywords

Brachytherapy; Prognosis; Prostate cancer; Treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BEAM THERAPY; BRACHYTHERAPY; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CRYOSURGERY; EARLY DIAGNOSIS; HUMAN; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; URINE INCONTINENCE;

CRYOSURGERY; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0034562784     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00284-X     Document Type: Conference Paper

References (64)

1. Deferred treatment of locally advanced non-metastatic prostate cancer: a long-term follow-up
2. Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities
3. External beam radiation monotherapy for prostate cancer
4. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
5. Statistical considerations when assessing outcomes following treatment for prostate cancer
6. Patient-reported complications after cryoablation therapy for prostate cancer
7. Control of prostate cancer with radiotherapy: long-term results
8. Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant
9. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and Goserelin
10. Neoadjuvant androgen ablation for localized prostatic cancer: pathology methods, surgical end points and meta-analysis of randomized trials
11. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy
12. Potency, continence and complication rates in 1870 consecutive radical retropubic prostatectomies
13. Results of conservative management of clinically localized prostate cancer
14. Cryosurgical ablation of the prostate in men with an unfavorable presentation of clinically localized prostate cancer (abstract 1378)
15. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial
16. Report of the Consensus Workshop on Screening and Global Strategy for Prostate Cancer
17. Incontinence after radical prostatectomy
18. Patient reported complications and follow-up treatment after radical prostatectomy: the national Medicare experience: 1988-1990 (updated June 1993)
19. Results of radical prostatectomy in men with clinically localized prostate cancer
20. Radical perineal prostatectomy: definitive treatment for patients with localized prostate cancer
21. The Veterans Administration Cooperative Urological Research Group: prediction of prognosis for prostatic carcinoma by combined histological grading and clinical staging
22. Salvage brachytherapy for localized prostate cancer after radiotherapy failure
23. Laparoscopic radical prostatectomy: initial experience and preliminary assessment after 65 operations
24. The management of locally advanced prostate cancer
25. TP I125 seed implantation in prostate cancer guided by transrectal sound
26. Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening
27. Fox Chase Cancer Center: update on the treatment of prostate cancer with external beam irradiation
28. Radiotherapie conformationnelle
29. The efficacy of cryosurgical ablation of prostate cancer: The University of California
30. Screening decreases prostate cancer death: first analysis of the 1988 Quebec Prospective Randomized Controlled Trial
31. Cancer statistics 1998
32. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer
33. Population-based study of long-term survival in patients with clinically localized prostate cancer
34. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy: a population-based study
35. The National Cancer Database report on prostate carcinoma after the peak in incidence rates in the US
36. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on cancer studies 1974-1993
37. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer
38. after anatomic radical prostatectomy: the Johns Hopkins Experience after 10 years
39. Prostate specific antigen doubling time (PSADT): Gleason score and the time to PSA recurrence following radical prostatectomy predicts time to distant progression
40. The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
41. Quality of life after salvage cryotherapy: the impact of treatment parameters
42. Phase III trial of androgen suppression using goserelin in unfavourable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of the Radiation Therapy Oncology Group Protocol 85-31
43. Ten-year disease-free survival after transperineal sonography-guided lodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma
44. Is the percentage of cancer in biopsy cores predictive or extracapsular disease in TI-T2 prostate cancer?
45. The changing pattern of prostate cancer at the time of diagnosis: characteristics of prostate cancers detected in a population-based screening study (ERSPC Data, Rotterdam Region)
46. Long-term survival after radiotherapy alone: radiation therapy oncology group prostate cancer trials
47. BCL2 and P53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy
48. Quality of life and treatment outcomes
49. The results of prostate carcinoma screening in the US is reflected in the surveillance, epidemiology and end results program
50. Use of artificial neural networks for diagnosis, staging and prognosis prediction for prostate cancer
51. Epidemiology in prostate cancer
52. Prostate brachytherapy: treatment strategies
53. Should Gleason score 7 prostate cancer be considered a unique grade category?
54. The Management of Clinically Localized Prostate Cancer
55. Outcome Evaluation of the 1997 American Joint Committee on Cancer Staging System for Prostate Carcinoma Treated by Radiation Therapy
56. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer
57. Surgery or radiation: is there really a choice for early prostate cancer?
58. Radical retropubic prostatectomy
59. Prostate cancer: screening or watchful waiting?
60. Retropubic implantation of I125 in the treatment of carcinoma of the prostate
61. 0 prostatic carcinoma
62. Prostate specific antigen and RT for clinically localized prostate cancer
63. Long-term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma